Company profile
Regenosca SA
Regenosca’s patented technology TissueSpan results in off-the-shelf and ready to use implants to avoid a second surgical site in soft tissue repair surgeries. They are engineered to be a noninvasive alternative to patient’s own tissue grafts that are currently used in clinics. Proof-of-concept is validated in an ongoing First-in-Man study where implants were successfully used to repair urethral strictures. The gold standard treatment is the use of patient’s own inner mouth tissue. Avoiding tissue harvesting means less pain, lower risks of complications, and shorter surgery times. TissueSpan implants will render soft tissue repair less invasive and fill the gap of missing biomaterials.
Source: startup.ch